Issue Contents

Volume 140: Themed Issue: Placenta accreta spectrum disorders

  • March 2018
  • Pages e1–e4, 259–380
Brief Detailed

Issue Information

SPECIAL EDITORIAL

FIGO GUIDELINES

REVIEW ARTICLE

Obstetrics

CLINICAL ARTICLES

International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders

Authors
Margarida Cal, Diogo Ayres‐de‐Campos, Eric Jauniaux
First Published:
Vol:
140,
Pages:
307–311
DOI:
10.1002/ijgo.12391

Wide variations existed in the diagnosis and management of placenta accreta spectrum disorders; however, most respondents favored cesarean hysterectomy with the placenta left in situ.

Placenta accreta spectrum disorder trends in the context of the universal two‐child policy in China and the risk of hysterectomy

Authors
Chanjuan Zeng, Mengyuan Yang, Yiling Ding, Siqi Duan, Yang Zhou
First Published:
Vol:
140,
Pages:
312–318
DOI:
10.1002/ijgo.12418

Increasing elective repeat cesarean delivery and placenta accreta spectrum disorder rates were observed at a tertiary hospital in China. Hysterectomy was associated with invasive depth.

Changes in ultrasonography indicators of abnormally invasive placenta during pregnancy

Authors
Giuseppe Calì, Ilan E. Timor‐Trisch, Josè Palacios‐Jaraquemada, Ana Monteaugudo, Francesco Forlani, Gabriella Minneci, Francesca Foti, Danilo Buca, Alessandra Familiari, Giovanni Scambia, et al
First Published:
Vol:
140,
Pages:
319–325
DOI:
10.1002/ijgo.12413

The prevalence of ultrasonography signs suggestive of abnormally invasive placenta changed through pregnancy; the prevalence was higher in placenta percreta compared with accreta or increta.

Interobserver agreement on standardized ultrasound and histopathologic signs for the prenatal diagnosis of placenta accreta spectrum disorders

Authors
Nurit Zosmer, Eric Jauniaux, Catey Bunce, Jenie Panaiotova, Hizbullah Shaikh, Kypros H. Nicholaides
First Published:
Vol:
140,
Pages:
326–331
DOI:
10.1002/ijgo.12389

A high degree of interobserver agreement was found for most ultrasound signs and histopathologic grading in the prenatal diagnosis of placenta accreta spectrum disorders.

Retrospective multicenter study of leaving the placenta in situ for patients with placenta previa on a cesarean scar

Authors
Kei Miyakoshi, Toshimitsu Otani, Eiji Kondoh, Shintaro Makino, Mamoru Tanaka, Satoru Takeda, the Perinatal Research Network Group in Japan
First Published:
Vol:
140,
Pages:
345–351
DOI:
10.1002/ijgo.12397

Leaving the placenta in situ could be an option for treating placenta accreta spectrum disorders; close follow‐up for several months after delivery is necessary.

Case series of outcomes of a standardized surgical approach for placenta percreta for prevention of ureteral lesions

Authors
David Atallah, Malak Moubarak, Malek Nassar, Bernard Kassab, Michel Ghossain, Nadine El Kassis
First Published:
Vol:
140,
Pages:
352–356
DOI:
10.1002/ijgo.12402

A specialized technique based on gynecologic oncologic experience was found to be effective in preventing ureteral lesions among women treated surgically for placenta percreta.

Matsubara–Takahashi cervix‐holding technique for massive postpartum hemorrhage in patients with placenta previa with or without placenta accreta spectrum disorders

Authors
Hironori Takahashi, Akihide Ohkuchi, Rie Usui, Hirotada Suzuki, Yosuke Baba, Shigeki Matsubara
First Published:
Vol:
140,
Pages:
357–364
DOI:
10.1002/ijgo.12390

Holding both the anterior and posterior cervical lips with forceps was successfully used to achieve hemostasis in patients with postpartum hemorrhage.

Retrospective analysis of obstetric and anesthetic management of patients with placenta accreta spectrum disorders

Authors
Efrain Riveros‐Perez, Cristina Wood
First Published:
Vol:
140,
Pages:
370–374
DOI:
10.1002/ijgo.12366

Interdisciplinary approaches and sequential combined spinal–epidural technique transitioning to general anesthesia were both safe and advisable for women with placenta accreta spectrum disorders.

BRIEF COMMUNICATIONS

Maternal deaths in Japan due to abnormally invasive placenta

Authors
Junichi Hasegawa, Hiroaki Tanaka, Shinji Katsuragi, Akihiko Sekizawa, Isamu Ishiwata, Tomoaki Ikeda, on behalf of the Maternal Death Exploratory Committee in Japan and the Japan Association of Obstetricians and Gynecologists
First Published:
Vol:
140,
Pages:
375–376
DOI:
10.1002/ijgo.12368

Treatment of abnormally invasive placenta in Japan should be performed in well‐resourced health centers; patients need to be transferred as necessary to prevent maternal death.